학술논문

Randomized comparison between KTd and KRd induction therapy followed by maintenance therapy with K or observation in transplant-ineligible patients with newly diagnosed multiple myeloma.
Document Type
Report
Author
Ludwig H; Department of Medicine I, Clinic Ottakring, Wilhelminen Cancer Research Institute, Vienna, Austria.; Melchardt T; Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Cancer Cluster Salzburg, Salzburg, Austria.; Sormann S; Department of Hematology, University Clinic for Internal Medicine, Graz, Austria.; Schreder M; Department of Medicine I, Clinic Ottakring, Vienna, Austria.; Andel J; Department of Internal Medicine II, Pyhrn-Eisenwurzen Klinikum Steyr, Steyr, Austria.; Hartmann B; Department of Internal Medicine II, LKH Rankweil, Rankweil, Austria.; Tinchon C; Department for Hematology, Oncology and Palliative Care, LKH Hochsteiermark, Standort Leoben, Standort Leoben, Austria.; Zojer N; Department of Medicine I, Clinic Ottakring, Vienna, Austria.; Gunsilius E; Department of Internal Medicine V, Medical University Innsbruck, Innsbruck, Austria.; Podar K; Department of Internal Medicine II, University Hospital Krems, Krems an der Donau, Austria.; Molecular Oncology and Hematology Unit, Karl Landsteiner University of Health Sciences, Krems an der Donau, Austria.; Egle A; Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Cancer Cluster Salzburg, Salzburg, Austria.; Willenbacher W; Department of Internal Medicine V, Medical University Innsbruck, Innsbruck, Austria.; syndena GmbH, Connect to Cure, Innsbruck, Austria.; Wöll E; Department of Internal Medicine, St. Vinzenz Krankenhaus Zams, Zams, Austria.; Ruckser R; Department of Medicine II, Clinic Donaustadt, Vienna, Austria.; Bozic B; Department of Medicine II, Clinic Donaustadt, Vienna, Austria.; Krauth MT; University Clinic for Internal Medicine I, AKH, Medical University of Vienna, Vienna, Austria.; Petzer A; Department of Internal Medicine I, BHS Linz, Linz, Austria.; Schmitt C; Clinic for Internal Medicine 3, Kepler University Clinic Linz, Linz, Austria.; Machherndl-Spandl S; Department of Internal Medicine I, Elisabethinen, Linz, Austria.; Agis H; Department of Internal Medicine I, Division of Oncology, Medical University Vienna, Vienna, Austria.; Fillitz M; Department of Internal Medicine, Hanusch Krankenhaus, Vienna, Austria.; Wang SY; Medical Clinic and Policlinic I, University Clinic Leipzig, Leipzig, Germany.; Zabernigg A; Department of Internal Medicine, Kufstein County Hospital, Kufstein, Austria.; Knop S; Klinik für Innere Medizin 5, Schwerpunkt Onkologie/Hämatologie, Klinikum Nürnberg Nord, Nürnberg, Germany.; Paiva B; Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), CCUN, IDISNA, Pamplona, Spain.; Greil R; Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Cancer Cluster Salzburg, Salzburg, Austria.
Source
Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE
Subject
Language
English
Abstract
Randomized comparison between KTd and KRd induction followed by second randomization to carfilzomib in transplant-ineligable patients with newly diagnosed multiple myeloma.
(© 2024 Wiley Periodicals LLC.)